Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
E.N.T., UTI, RTI, skin and soft tissues, bone, joint, GI, intra-abdominal, pelvic and severe infections, gonorrhoea. Clinical selection for Sparfloxacin should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Orally, 100 to 300mg in 1 or 2 divided doses daily.
Local irritation at the site of injection, GI disturbances, dizziness, headache, tremor, confusion, convulsions, rashes, blurred vision, psychotic reactions, impaired vision, impaired taste and smell sensation, Stevens-Johnson syndrome, hot flushes, skin rashes, migraine, photosensitivity
Store as labelled. Keep out of reach of children.